Schedule 13D ownership disclosure

ARIAD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 04033A100

Event date: 2014-08-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,850,000
Percent of class
6.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-14-000593
Form type
SC 13D/A
Filer
ARIAD PHARMACEUTICALS INC
CIK
CIK 884731
Filed
Aug 20, 2014
Reporting period
Aug 18, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub